Höhn F, Kretz F T A, Pavlidis M
Augenklinik Klinikum Pforzheim, Kanzlerstr. 2-6, 75175, Pforzheim, Deutschland,
Ophthalmologe. 2014 Sep;111(9):882-6. doi: 10.1007/s00347-014-3158-1.
The aim of the surgical treatment of retinal detachment is retinal reattachment especially of the central portion for the best possible regeneration of functional visual outcome.
Total and subtotal retinal detachments in combination with macular involvement were investigated.
After complete 20 or 23-gauge pars plana vitrectomy (ppV) the internal limiting membrane (ILM) was stained with Brilliant Blue for 30 s. The detached and more mobile central retina was weighted and stabilized with decaline so that the raised ILM could be carefully peeled away under the decaline level. Removal of residual decaline was followed by drainage of subretinal fluids through the retinal foramen and fluid-air exchange. To prevent renewed detachment circular laser coagulation was performed under air and followed by tamponade with silicone oil or SF6 gas depending on the status of the retina.
The surgical intervention could be successfully performed in all selected patients with a primary reattachment rate of 100 %. In the 12-month follow-up period no renewed detachment or formation of a secondary epiretinal membrane was observed. The postoperative visual acuity (VA) showed a statistically significant increase (p < 0.0001) in the Wilcoxon test for paired samples.
Primary vitrectomy with ILM peeling under decaline is a promising but ambitious surgical intervention for the treatment of incomplete and complete retinal detachment with and without proliferative vitreoretinopathy.
视网膜脱离手术治疗的目的是实现视网膜复位,尤其是中央部分的复位,以尽可能实现功能性视力结果的最佳再生。
研究了伴有黄斑受累的完全性和不完全性视网膜脱离。
在完成20或23G经平坦部玻璃体切除术(ppV)后,用亮蓝对内界膜(ILM)染色30秒。用十氢化萘对脱离且活动度更大的中央视网膜进行加压并使其稳定,以便在十氢化萘液面下小心地剥除抬起的ILM。去除残留的十氢化萘后,通过视网膜裂孔引流视网膜下液并进行液气交换。为防止再次脱离,在气体填充下进行环形激光光凝,然后根据视网膜情况用硅油或SF6气体进行填充。
所有选定患者均成功进行了手术干预,初次复位率为100%。在12个月的随访期内,未观察到再次脱离或继发性视网膜前膜形成。配对样本的Wilcoxon检验显示术后视力(VA)有统计学意义的提高(p < 0.0001)。
在十氢化萘下进行内界膜剥除的初次玻璃体切除术是一种有前景但颇具挑战性的手术干预方法,用于治疗伴有或不伴有增殖性玻璃体视网膜病变的完全性和不完全性视网膜脱离。